Back to KROS

Connor, Clark & Lunn Investment Management Ltd. → KROS

Connor, Clark & Lunn Investment Management Ltd. KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$822K
Q3 2026
Peak value
$6.5M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$5.3M
Q4 2025$6.5M
Q1 2026$2.8M
Q2 2026$1.4M
Q3 2026$822K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$822K72.1K——
Q2 2026$1.4M127.9K——
Q1 2026$2.8M257.9K——
Q4 2025$6.5M321.3K——
Q3 2025$5.3M335.2K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other Connor, Clark & Lunn Investment Management Ltd. positions

RYLBF

ROYAL BK CDA

$2.3B
RYLBF

ROYAL BK CDA

$2.3B
RYLBF

ROYAL BK CDA

$2B
NVDA

NVIDIA CORPORATION

$1.8B
RYLBF

ROYAL BK CDA

$1.8B
RYLBF

ROYAL BK CDA

$1.6B
TDBCP

TORONTO DOMINION BK ONT

$1.6B
TDBCP

TORONTO DOMINION BK ONT

$1.4B